Feil Gerhard, Maurer Sabine, Nagele Udo, Krug Jutta, Bock Conny, Sievert Karl-Dietrich, Stenzl Arnulf
Department of Urology, University of Tübingen, Hoppe-Seyler-Strasse 3, D-72076 Tübingen, Germany.
Eur Urol. 2008 May;53(5):1066-72. doi: 10.1016/j.eururo.2007.10.026. Epub 2007 Oct 23.
To investigate the immunoreactivity of p63 in monolayered and stratified human urothelial cell cultures and in normal urothelial tissues to assess the differentiation status of in vitro stratified urothelial constructs.
p63 expression was detected immunohistochemically in native normal human bladder, ureter, and renal pelvis tissues and immunocytochemically in monolayered urothelial cell cultures and urothelial constructs stratified in vitro. Additionally, expression of pancytokeratin, cytokeratin 20 (CK20), uroplakin III, and fibroblast surface antigen was investigated.
In native tissues, urothelial cell layers showed the most intensive p63 staining in the basal cells; the superficial umbrella cells were predominantly negative. Monolayered urothelial cell cultures revealed reduced p63 expression with ongoing culture passages. In vitro stratified urothelial constructs exhibited p63 expression similar to that of native urothelium. CK20-reactive cells were absent in the monolayered cultures but present in the stratified cell cultures and in the urothelial constructs. In native urothelium, only superficial cells stained positive for CK20. Uroplakin III was not present in either monolayered urothelial cell cultures or stratified urothelial constructs. Cultured cells were always positive for pancytokeratin and negative for fibroblast surface antigen.
p63 is a new biomarker for differentiation and stratification of urothelium created in vitro. For proposed clinical applications of in vitro stratified urothelium in reconstructive urology, urothelial constructs should exhibit expression of significant marker proteins similar to that of native urothelium. Our results show such similarity of expression for pancytokeratin, p63, and CK20, an encouraging possibility for confirming the functionality of tissue-engineered urothelia after clinical application.
研究p63在人单层和分层尿路上皮细胞培养物以及正常尿路组织中的免疫反应性,以评估体外分层尿路构建体的分化状态。
采用免疫组织化学方法检测正常人膀胱、输尿管和肾盂组织中p63的表达,采用免疫细胞化学方法检测单层尿路上皮细胞培养物和体外分层的尿路构建体中p63的表达。此外,还研究了全细胞角蛋白、细胞角蛋白20(CK20)、尿血小板蛋白III和成纤维细胞表面抗原的表达。
在天然组织中,尿路上皮层的基底细胞p63染色最强;表层伞细胞主要为阴性。单层尿路上皮细胞培养物随着传代次数的增加p63表达降低。体外分层的尿路构建体表现出与天然尿路上皮相似的p63表达。单层培养物中不存在CK20反应性细胞,但在分层细胞培养物和尿路构建体中存在。在天然尿路上皮中,只有表层细胞CK20染色呈阳性。尿血小板蛋白III在单层尿路上皮细胞培养物或分层尿路构建体中均不存在。培养细胞全细胞角蛋白始终呈阳性,成纤维细胞表面抗原呈阴性。
p63是体外构建尿路上皮分化和分层的一种新的生物标志物。对于体外分层尿路上皮在重建泌尿外科中的拟用临床应用,尿路构建体应表现出与天然尿路上皮相似的重要标志物蛋白表达。我们的结果显示了全细胞角蛋白、p63和CK20表达的这种相似性,这为临床应用后确认组织工程化尿路上皮的功能提供了令人鼓舞的可能性。